James G. Onder
St. Louis, MO (PRWEB) June 18, 2014
The Androgel Testosterone Lawsuits website is a new resource from national product and family safety attorneys at The Onder Law Firm. Based in St. Louis, these testosterone lawyers have also represented clients in major pharmaceutical, product liability, and personal injury lawsuits, and offer expertise in representing the interests of individuals and families against major corporations. Persons seeking information about filing an Androgel testosterone lawsuit related to heart attack or stroke may contact the firm for a free testosterone lawsuit case review through the new website.
Androgel lawsuits have gained momentum in the first half of 2014, since the FDA issued a January 31, 2014 Safety Alert* indicating the federal agency “is investigating the risk of stroke, heart attack, and death in men taking FDA-approved testosterone products”. The safety alert cited two recent studies which indicate men using testosterone therapies face a higher risk of heart attack and stroke. In the days immediately following the FDA alert, several AndroGel lawsuits were filed against AbbVie by persons who suffered heart attack and stroke while taking testosterone (Aurecchia v. AbbVie Inc. (ABBV), 14-cv-00772; Benn v. AbbVie, 14-cv-00774; Gallagher v. AbbVie Inc., 14-cv-00776; Marino v. AbbVie Inc., 14-cv-00777 and Myers v. AbbVie Inc., 14-cv-00780; U.S. District Court, Northern District of Illinois). According to a Bloomberg News piece from February 5, 2014**, these initial Androgel lawsuits asserted the plaintiffs were unaware of the cardiovascular risks associated with the drug, and were subject to misinforming advertising regarding the safety of testosterone therapy. The article outlines the allegations made by Androgel lawsuits: “Abbott and AbbVie ‘deceived potential AndroGel users by relaying positive information through the press, including testimonials from retired professional athletes’ and statistics suggesting a widespread need for the drugs, ‘while downplaying known adverse and serious health risks,’ according to the complaints.”
Recent court documents*** indicate that more than 45 Androgel lawsuits have been consolidated as a Multi-District Litigation (MDL) in the Northern Illinois branch of U.S. District Court where these claims were first filed. The Androgel lawsuits will be consolidated with similar lawsuits for other testosterone replacement therapies in which plaintiffs are claiming a connection between testosterone and heart attack or stroke incidents. According to the firm’s Androgel lawyers, MDL is a court process designed to expedite the resolution of similar cases, such as testosterone lawsuits. Each plaintiff in the testosterone lawsuit MDL will receive compensate commensurate to their suffering and losses.
Androgel is the leading product among more than a dozen testosterone replacement therapies available to U.S. patients. According to the FDA warning on testosterone and heart attack risks, testosterone replacement therapies have been approved by the FDA “only for use in men who lack or have low testosterone levels in conjunction with an associated medical condition” such as “failure of the testicles to produce testosterone because of… genetic problems or chemotherapy”. Men who do not have a documented medical problem associated with low testosterone levels are not medically indicated for taking Androgel or another testosterone drug. The combined testosterone lawsuits will include claims for Androgel and other testosterone replacement therapies.
The Onder Law Firm’s Androgel attorneys will provide a confidential case evaluation at no charge for persons who suffered stroke or heart attack while taking testosterone. Individuals who fit this description may contact a lawyer through the firm’s website for a no-obligation consultation to determine whether they have grounds for a testosterone lawsuit. The firm’s Androgel lawyers believe men who meet this description may be entitled to real compensation for the harm and damages they sustained while the makers and manufacturers of testosterone replacement therapies benefited from product sales. The Onder Law Firm welcomes AndroGel lawsuit or other testosterone case inquiries from law firms in regards to handling them or working as co-counsel.
About The Onder Law Firm
Onder, Shelton, O’Leary & Peterson, LLC is a St. Louis based personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The pharmaceutical and medical device litigators at The Onder Law Firm have represented thousands of Americans in lawsuits against multinational conglomerates from products liability for manufacture of defective or dangerous products to deceptive advertising practices. Other firms throughout the nation often seek its experience and expertise on complex litigation. It is also a recognized leader in products liability cases such as window blind cord strangulation. The Onder Law Firm offers information from AndroGel lawyers handling claims for stroke, heart attack, or other cardiovascular incidents at http://www.androgeltestosteronelawsuits.com.
*fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm384225.htm?utm_source=rss&utm_medium=rss&utm_campaign=testosterone-products-drug-safety-communication-fda-investigating-risk-of-cardiovascular-events
**bloomberg.com/news/2014-02-05/abbott-labs-sued-by-five-men-claiming-androgel-injuries.html
***jpml.uscourts.gov/sites/jpml/files/MDL-2545-Initial_Transfer-05-14.pdf